Clinical and laboratory aspects of 3,3′,5′-triiodothyronine (reverse T3)
The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Abstract
Reverse T3 (3,3′,5′-triiodothyronine or rT3) is the third most abundant iodothyronine circulating in human blood and is produced by the inner ring deiodination of the pro-hormone thyroxine (T4). Unlike the more abundant and active metabolite T3, the measurement of serum rT3 is yet to find a routine clinical application. As rT3 binds weakly to the T3 thyroid nuclear hormone receptors, it is thought to represent an inactive end-product of thyroid hormone metabolism, diverting T4 away from T3 production. The analysis of serum rT3 has, up until recently, been measured by competitive radioimmunoassay, but these methods have been superseded by mass-spectrometric methods which are less susceptible to interference from other more abundant iodothyronines. Serum rT3 concentration is increased as part of the non-thyroidal illness syndrome, and by administration of common medications such as amiodarone which inhibit the metabolism of rT3. Serum rT3 concentration is also affected by genetic conditions that affect the iodothyronine deiodinases, as well as thyroid transporters and transport proteins. Analysis of rT3 can provide a useful diagnostic fingerprint for these conditions. rT3 has been shown to bind extra-nuclear iodothyronine receptors with a potential role in cell proliferation; however, the clinical relevance of these findings awaits further study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unlike the active T4 metabolite T3, rT3 is an inactive metabolite of T4 as it does not bind or compete with T3 at the T3 receptor.”
In the citing paper
“However, as rT3 assays are not widely available, measurement of T3 is more practical, cheaper, and as effective as measuring rT3 if nonthyroidal illness syndrome is suspected.”
Citations
Cites
The Effects of Amiodarone on the Thyroid*
Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0427 · Cited by 551
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Non-Thyroidal Illness in the ICU: A Syndrome with Different Faces
Van den Berghe, G. (2014) · Thyroid® · doi:10.1089/thy.2014.0201 · Cited by 316
Schoenmakers, E., Agostini, M., Mitchell, C., Schoenmakers, N., Papp, L., Rajanayagam, O., Padidela, R., Ceron-Gutierrez, L., Doffinger, R., Prevosto, C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43653 · Cited by 315 · cited 1×
“The lack of thyroid deiodinase function presents with a characteristic thyroid function test of high serum rT3 and T4, and borderline low T3, which may the first indication that SBP2 action is impaired.(58)”
BackgroundSelf-citationSakurai, A., Takeda, K., Ain, K., Ceccarelli, P., Nakai, A., Seino, S., Bell, G. I., Refetoff, S., & DeGroot, L. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8977 · Cited by 268
A Radioimmunoassay for Measurement of 3,3′, 5′-Triiodothyronine (Reverse T3)
Chopra, I. J. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107795 · Cited by 251
Peeters, R. P., Wouters, P. J., van Toor, H., Kaptein, E., Visser, T. J., & Van den Berghe, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0535 · Cited by 251
Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T. I., Poehlman, E. T., Shuldiner, A. R., & Celi, F. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.880 · Cited by 205
The MCT8 thyroid hormone transporter and Allan–Herndon–Dudley syndrome
Schwartz, C. E., & Stevenson, R. E. (2007) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.03.009 · Cited by 164 · cited 1×
“Mutations in the thyroid hormone transporter MCT8 are responsible for the X-linked mental retardation syndrome Allan Herndon Dudley syndrome (AHDS).(59) MCT8 is a specific thyroid hormone transporter that is widely expressed, but notably in the CNS, where it is the major thyroid transmembrane transporter.”
BackgroundBurch, H. B. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1901214 · Cited by 164
Eskes, S. A., & Wiersinga, W. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.001 · Cited by 148
Inherited defects of thyroxine-binding proteins
Pappa, T., Ferrara, A. M., & Refetoff, S. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.09.002 · Cited by 139 · cited 4×
“The first quantitative assay for rT3 was a radioimmunoassay (RIA) developed by Chopra in 1974.9 The consensus from these studies and results from other RIAs subsequently developed was that rT3 is a normal constituent of healthy human plasma, and that the reciprocal conversion of T4 to T3 or to rT3 represents activatin…”
BackgroundInfluentialDIAGNOSIS OF ENDOCRINE DISEASE: How reliable are free thyroid and total T3 hormone assays?
Welsh, K. J., & Soldin, S. J. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0193 · Cited by 124 · cited 1×
“Considerable efforts have been expended to measure both the free fraction of T4 (fT4) and T3 (fT3), as this best correlates with biological effects.(12) This has not been pursued for rT3 due to the lack of an obvious biological target, although equilibrium dialysis methods would be appropriate for this task.”
BackgroundWiersinga, W. M., & CHOPRA, I. J. (1982) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(82)84024-x · Cited by 113
Analysis of thyroid hormones in serum by liquid chromatography-tandem mass spectrometry
Wang, D., & Stapleton, H. M. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3705-9 · Cited by 107
Santini, F., Chiovato, L., Ghirri, P., Lapi, P., Mammoli, C., Montanelli, L., Scartabelli, G., Ceccarini, G., Coccoli, L., Chopra, I. J., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5439 · Cited by 100
The Deiodinase Trio and Thyroid Hormone Signaling
Bianco, A. C., & da Conceição, R. R. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7902-8_8 · Cited by 96 · cited 9×
“Bold fonts indicate proposed major physiological roles.(2) 30 Annals of Clinical Biochemistry 58(1)”
BackgroundInfluentialThyroid Hormone Interactions: Molecular Conformation, Protein Binding, and Hormone Action*
Cody, V. (1980) · Endocrine Reviews · doi:10.1210/edrv-1-2-140 · Cited by 94
Lem, A. J., de Rijke, Y. B., van Toor, H., de Ridder, M. A. J., Visser, T. J., & Hokken-Koelega, A. C. S. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1759 · Cited by 93 · cited 1×
“25 nmol/ L) throughout infancy.(43) Concentrations then increase with age, doubling in centenarians compared with young adults(44); this is thought to reflect a genuine age-related reduction in 50 deiodination rather than confounding effects of carbohydrate intake or NTIS.”
BackgroundSerum Thyroid Function, Mortality and Disability in Advanced Old Age: The Newcastle 85+ Study
Pearce, S. H. S., Razvi, S., Yadegarfar, M. E., Martin-Ruiz, C., Kingston, A., Collerton, J., Visser, T. J., Kirkwood, T. B., & Jagger, C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1935 · Cited by 91
Mousa, S. A., Lin, H., Tang, H. Y., Hercbergs, A. A., Luidens, M. K., & Davis, P. J. (2014) · Angiogenesis · doi:10.1007/s10456-014-9418-5 · Cited by 81
LoPresti, J. S., Eigen, A., Kaptein, E., Anderson, K. P., Spencer, C. A., & Nicoloff, J. T. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114343 · Cited by 80
Magri, F., Muzzoni, B., Cravello, L., Fioravanti, M., Busconi, L., Camozzi, D., Vignati, G., & Ferrari, E. (2002) · Metabolism · doi:10.1053/meta.2002.28968 · Cited by 78
Resistance to Thyroid Hormone due to Heterozygous Mutations in Thyroid Hormone Receptor Alpha
van Gucht, A. L. M., Moran, C., Meima, M. E., Visser, W. E., Chatterjee, K., Visser, T. J., & Peeters, R. P. (2017) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.02.001 · Cited by 74
Thyroid Hormone Transport and Transporters
Braun, D., & Schweizer, U. (2018) · Vitamins and Hormones · doi:10.1016/bs.vh.2017.04.005 · Cited by 74
Thyroid Hormone Receptor α and Regulation of Type 3 Deiodinase
Barca-Mayo, O., Liao, X.-H., Alonso, M., Di Cosmo, C., Hernandez, A., Refetoff, S., & Weiss, R. E. (2011) · Molecular Endocrinology · doi:10.1210/me.2010-0213 · Cited by 73 · cited 5×
“Changes in expression DIO1 or DIO3 expression are likely candidates for this effect; indeed, studies in THRa knock-out mice have demonstrated reduced expression of DIO3.(65)”
BackgroundInfluentialPropranolol and thyroid hormone metabolism
WIERSINGA, W. M. (1991) · Thyroid · doi:10.1089/thy.1991.1.273 · Cited by 70 · cited 1×
“Amiodarone has complex effects on thyroid function in part due to its high iodine content, but also as an inhibitor of outer ring deiodination by DIOs 1 and 2.(40) Inhibition of DIO1 causes an increase in serum rT3, as rT3 clearance is diminished.”
BackgroundMolecular Basis of Nongenomic Actions of Thyroid Hormone
Davis, P. J., Leonard, J. L., Lin, H., Leinung, M. C., & Mousa, S. A. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.06.001 · Cited by 68 · cited 2×
“Unlike the nuclear hormone receptors, these novel receptors are not specific for T3 and can be activated by T4 (previously assumed to be a prohormone) and rT3 (presumed to be an inactive metabolite) directly, and also by a plethora of other thyroid hormone metabolites and derivates that do not bind THRa or b.(4) rT3 a…”
BackgroundSystematic review and meta-analysis on the effect of soy on thyroid function
Otun, J., Sahebkar, A., Östlundh, L., Atkin, S. L., & Sathyapalan, T. (2019) · Scientific Reports · doi:10.1038/s41598-019-40647-x · Cited by 68 · cited 1×
“However, concerns regarding a negative impact of soy consumption on thyroid function have not been substantiated by meta-analysis.(42)”
BackgroundThe colorful diversity of thyroid hormone metabolites
Köhrle, J. (2019) · European Thyroid Journal · doi:10.1159/000497141 · Cited by 67 · cited 16×
“2,3 DIO3 is expressed predominantly in the brain and skin and generates rT3 by the by inner ring deiodination of T4 (Figure 1). rT3 is rapidly cleared by further deiodination to 3,3-T2 by DIO1, expressed predominantly in the liver and kidney, and also possibly DIO2 which is widely expressed in other tissues.2 The cont…”
BackgroundInfluentialHansen, M. A., Luong, X. G., Sedlak, D. L., Helbing, C. C., & Hayes, T. B. (2016) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-016-9614-9 · Cited by 61 · cited 1×
“With the discovery of a variety of other biologically active thyroid metabolites (reviewed by K€ ohrle)(21) and their potential role in peripheral regulation of thyroid hormone activity (reviewed by Little 2018),(22) the selectivity of MS methods has been exploited to for the analysis of large panels of thyroid hormon…”
BackgroundMoran, C., Agostini, M., McGowan, A., Schoenmakers, E., Fairall, L., Lyons, G., Rajanayagam, O., Watson, L., Offiah, A., Barton, J., et al. (2017) · Thyroid® · doi:10.1089/thy.2017.0157 · Cited by 60
Loun, B., & Hage, D. S. (1995) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/0378-4347(94)00547-i · Cited by 57
Relationship between Psychotropic Drugs and Thyroid Function: A Review
Sauvage, M.-F., Marquet, P., Rousseau, A., Raby, C., Buxeraud, J., & Lachâtre, G. (1998) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1998.8367 · Cited by 55
Type 3 deiodinase and solid tumors: an intriguing pair
Dentice, M., Antonini, D., & Salvatore, D. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.833189 · Cited by 52
Reverse T 3 Does Not Reliably Differentiate Hypothyroid Sick Syndrome from Euthyroid Sick Syndrome
Burmeister, L. A. (1995) · Thyroid · doi:10.1089/thy.1995.5.435 · Cited by 49 · cited 2×
“The inactivation of T4 to rT3 is an established physiological response to acute illness (the non-thyroidal illness syndrome or NTIS) or starvation, although a clinical need for rT3 analysis in this situation has yet to be established.(5) Commonly used pharmacological agents such as amiodarone can inhibit 50 deiodinati…”
BackgroundMethodYasar, Z. A., Kıraklı, C., Yılmaz, U., Uçar, Z. Z., & Talay, F. (2014) · Hormones and Cancer · doi:10.1007/s12672-014-0183-0 · Cited by 46
Inherited defects in thyroid hormone cell-membrane transport and metabolism
Fu, J., & Dumitrescu, A. M. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.05.014 · Cited by 41 · cited 8×
“This gives the pathognomonic pattern of thyroid function tests in AHDS with low serum rT3 concentration, borderline low T4 with high T3 and borderline elevations of TSH.(60)”
BackgroundInfluentialMedici, M., Visser, T. J., & Peeters, R. P. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.04.002 · Cited by 39
Syndromes of Resistance to Thyroid Hormone Action
Persani, L., & Campi, I. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_5 · Cited by 36 · cited 3×
“Email: david.halsall@nhs.net THR receptors, and is also unlikely to act as a physiologically relevant competitor for T3 binding to THRb.”
BackgroundFan, W., Mao, X., He, M., Chen, B., & Hu, B. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.10.022 · Cited by 36 · cited 1×
“Since then, several rT3 methods have been published, which are amenable to the routine clinical chemistry laboratory including methods for use in human tissue samples(18,19) and urine.(20) With the discovery of a variety of other biologically active thyroid metabolites (reviewed by K€ ohrle)(21) and their potential ro…”
MethodJacobs, A., Derese, I., Vander Perre, S., van Puffelen, E., Verstraete, S., Pauwels, L., Verbruggen, S., Wouters, P., Langouche, L., Garcia Guerra, G., et al. (2019) · Thyroid · doi:10.1089/thy.2018.0420 · Cited by 35
Consumptive hypothyroidism: a case report and review of the literature
Jassam, N., Visser, T. J., Brisco, T., Bathia, D., McClean, P., & Barth, J. H. (2011) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.010170 · Cited by 32 · cited 9×
“37 The isoflavones present in soy have been shown to cause a transient rise in rT3 with a concomitant increase in TSH.41 However, concerns regarding a negative impact of soy consumption on thyroid function have not been substantiated by meta-analysis.42”
BackgroundInfluentialRoche, E. F., McGowan, A., Koulouri, O., Turgeon, M., Nicholas, A. K., Heffernan, E., El‐Khairi, R., Abid, N., Lyons, G., Halsall, D., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13827 · Cited by 29
Self-citationLi, Z., Giesert, F., Weisenhorn, D. M. V., Main, K. M., Skakkebæk, N. E., Kiviranta, H., Toppari, J., Feldt‐Rasmussen, U., Shen, H., Schramm, K., et al. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.12.048 · Cited by 28
Nonthyroidal Illness Syndrome and Thyroid Hormone Actions at Integrin αvβ3
Hercbergs, A. H., Mousa, S. A., & Davis, P. J. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01939 · Cited by 27 · cited 2×
“However, rT3 has been shown to have a direct effect on the proliferation of human glioblastoma and breast cancer cell lines,(33) which may be of clinical consequence, particularly considering the NTIS where systemic rT3 concentrations can be dramatically elevated.(34)”
BackgroundRichards, K. H., Monk, R., Renko, K., Rathmann, D., Rijntjes, E., & Köhrle, J. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-01941-9 · Cited by 27 · cited 1×
“With the discovery of a variety of other biologically active thyroid metabolites (reviewed by K€ ohrle)(21) and their potential role in peripheral regulation of thyroid hormone activity (reviewed by Little 2018),(22) the selectivity of MS methods has been exploited to for the analysis of large panels of thyroid hormon…”
BackgroundAction of Reverse T3 on Cancer Cells
Lin, H., Tang, H.-Y., Leinung, M. C., Mousa, S. A., Hercbergs, A. H., & Davis, P. J. (2019) · Endocrine Research · doi:10.1080/07435800.2019.1600536 · Cited by 25 · cited 1×
“Recent studies have shown that rT3 can increase tumour proliferation by binding at the integrin avb3 receptor.(33) As NTI often accompanies cancer concomitant rise in rT3 may act to support tumour growth.”
BackgroundPatient-centered care: antecedents, triggers, and mediators.
Galland, L. (2006) · PubMed · Cited by 24
Schmidt, R. L., LoPresti, J. S., McDermott, M. T., Zick, S. M., & Straseski, J. A. (2018) · Thyroid · doi:10.1089/thy.2017.0645 · Cited by 23 · cited 2×
“The analysis of circulating rT3 is controversial; most clinical laboratories do not measure this metabolite, as its relevance to routine diagnosis or therapeutic intervention is questionable.(1) However, some practitioners advocate its measurement to optimize thyroxine replacement in hypothyroid patients, which is con…”
BackgroundTandem mass spectrometry of deprotonated iodothyronines
Couldwell, A. M., Thomas, M. C., Mitchell, T. W., Hulbert, A. J., & Blanksby, S. J. (2005) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.2061 · Cited by 21
Sakai, H., Nagao, H., Sakurai, M., Okumura, T., Nagai, Y., Shikuma, J., Ito, R., Imazu, T., Miwa, T., & Odawara, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138864 · Cited by 19 · cited 3×
“Reference intervals for serum rT3 are method dependent, given the potential for cross-reactivity of other thyroid hormone metabolites with immunoassays for rT3.(17) Serum rT3 concentration can also be significantly affected by carbohydrate deficiency or concurrent illness.”
MethodLocal Regulation of Thyroid Hormone Signaling
Little, A. G. (2017) · Vitamins and hormones · doi:10.1016/bs.vh.2017.06.004 · Cited by 17 · cited 1×
“…active thyroid metabolites (reviewed by K€ohrle)21 and their potential role in peripheral regulation of thyroid hormone activity (reviewed by Little 2018),22 the selectivity of MS methods has been exploited to for the analysis of large panels of thyroid hormone metabolites including rT3.”
BackgroundT3/rT3-Ratio is Associated with Insulin Resistance Independent of TSH
Ruhla, S., Arafat, A. M., Weickert, M. O., Osterhoff, M., Isken, F., Spranger, J., Schöfl, C., Pfeiffer, A. F. H., & Möhlig, M. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0030-1267997 · Cited by 14 · cited 1×
“The ratio of T3 to rT3 has been shown to positively associate with markers of insulin resistance and with gender, males having a lower T3:rT3 ratio.(51) These findings cannot be explained by changes in the pituitary thyroid axis, as demonstrated by a lack of response of serum TSH concentration.”
BackgroundKumar, A. P., Jin, H., Jo, S., Kim, C., Nam, S., & Lee, Y. (2009) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2009.07.004 · Cited by 12
Sathyapalan, T., Köhrle, J., Rijntjes, E., Rigby, A. S., Dargham, S. R., Kilpatrick, E. S., & Atkin, S. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00698 · Cited by 11 · cited 8×
“37 The isoflavones present in soy have been shown to cause a transient rise in rT3 with a concomitant increase in TSH.41 However, concerns regarding a negative impact of soy consumption on thyroid function have not been substantiated by meta-analysis.42”
BackgroundInfluentialConsumptive hypothyroidism associated with parotid infantile hemangioma
Corti, F. D., Crivellaro, C. E., Zanon, G. F., & Luzzatto, C. (2014) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2013-0420 · Cited by 9 · cited 9×
“37 The isoflavones present in soy have been shown to cause a transient rise in rT3 with a concomitant increase in TSH.41 However, concerns regarding a negative impact of soy consumption on thyroid function have not been substantiated by meta-analysis.42”
BackgroundInfluentialInternational survey of the radioimmunological measurement of serum reverse triiodothyronine
MEINHOLD, H., & Visser, T. J. (1980) · Clinica Chimica Acta · doi:10.1016/0009-8981(80)90114-x · Cited by 7 · cited 1×
“Unfortunately, the original RIAs were susceptible to both binding protein interferences and cross-reactivity with other far more abundant iodothyronines such as T4 itself.(10) Also, the RIA format is manual, time-consuming and requires the use of radioisotopes.”
BackgroundLC–MS/MS detection of thyroid hormone metabolites in tissue samples
Hoefig, C. S., & Köhrle, J. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.48 · Cited by 3
SCHAISON, G., THOMOPOULOS, P., Guillouzic, D. L., Thomas, G., & Moatti, M. (1984) · European Journal of Endocrinology · doi:10.1530/acta.0.1060338 · Cited by 3
Serum reverse T3 and amiodarone efficacy
Haberman, R. J., Ladenson, P. W., Griffith, L. S. C., & Veltri, E. P. (1989) · Clinical Cardiology · doi:10.1002/clc.4960120305 · Cited by 1
Research works printed but not linked: 5
- The non-thyroidal illness syndrome – PubMed, https://pubmed.ncbi.nlm.nih.gov/25905425/ (accessed 5 July 2020).
- Santini F, 1999, J Clin Endocrinol Metab, 84, 493
- Martino E, 2001, Endocr Rev, 22, 240
- Galland L., 2020, Altern Ther Health Med, 12, 62
- Sarne D., 2016, Thyroid Dis Manager
Cited by
Van Uytfanghe, K., Ehrenkranz, J., Halsall, D., Hoff, K., Loh, T. P., Spencer, C. A., Köhrle, J., & ATA Thyroid Function Tests Writing Group (2023) · Thyroid® · doi:10.1089/thy.2023.0169 · Cited by 100
“88 Measurement of rT3 is widely cited in the lay press as a potential marker to guide T4 or T3 therapy, however, there is currently no evidence to support this application.”
BackgroundSelf-citationSimultaneous Identification of Major Thyroid Hormones by a Nickel Immobilized Biological Nanopore
Wang, K., Yang, X., Xiao, Y., Cao, Z., Zhang, S., Zhang, P., & Huang, S. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c04024 · Cited by 21
Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV
Micali, C., Russotto, Y., Celesia, B. M., Santoro, L., Marıno, A., Pellicanò, G. F., Nunnari, G., & Rullo, E. V. (2022) · Infectious Disease Reports · doi:10.3390/idr14050071 · Cited by 23
“Sick euthyroid syndrome (SES), also known as nonthyroidal illness syndrome (NTIS), is a condition characterized by a consistent decrease in serum fT3 levels with normal fT4 and TSH levels and increased concentration of serum rT3 [45,46].”
BackgroundVanhorebeek, I., Derese, I., Gunst, J., Wouters, P. J., Hermans, G., & den Berghe, G. V. (2021) · Critical Care · doi:10.1186/s13054-021-03858-1 · Cited by 18
“Reverse T3 has long been considered an inactive metabolite of thyroid hormone, considering its weak affinity for nuclear thyroid hormone receptors [36].”
BackgroundXu, C., Gong, M., Wen, S., Zhou, M., Li, Y., & Zhou, L. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s349769 · Cited by 14
Metadata
- Authors
- Halsall, D. J., & Oddy, S.
- Affiliations
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Halsall, David J
- ORCID
- Halsall, David J
- Venue
- Annals of Clinical Biochemistry: International Journal of Laboratory Medicine
- Publisher
- SAGE Publications
- Published
- 2020-11-04
- Volume
- 58
- Issue
- 1
- Pages
- 29-37
- ISSN
- 0004-5632 (ISSN-L)
- 1758-1001
- OpenAlex
- W3091985994
- Cited by
- 28
- References
- 61
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 5 · 2023: 5 · 2022: 2 · 2021: 1
- FWCI
- 0.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Clinical Biochemistry International Journal of Laboratory Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- reverse T3, thyroid hormone metabolism, iodothyronine deiodinase, low T3 syndrome, amiodarone, thyroid hormone transporters, thyroid function tests
- MeSH terms
- Amiodarone, Euthyroid Sick Syndromes, Humans, Iodide Peroxidase, Thyroid Gland, Thyroxine, Triiodothyronine, Reverse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.